In several articles on this website, we have discussed the challenges of managing attention-deficit/ hyperactivity disorder (ADHD) during pregnancy and lactation/ breastfeeding. For links to these articles, please see Related Pages below.
In this article, we will answer the following question, which comes up repeatedly in my own clinical practice:
What are the potential risks of the amphetamine class of psychostimulant medications during lactation/breastfeeding (when they are taken under medical supervision and in therapeutic doses for the treatment of medical conditions like ADHD or narcolepsy)?
This content is for Monthly Membership and Yearly Membership members only.
Register
Register
Already a member? Log in here